Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-06

Clinical Trial Update: A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib

View source ↗

Summary

This clinical trial update reports the results of a retrospective observational study of patients with early-stage HER2-positive breast cancer treated with nera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • neratinib (neratinib)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Breast Cancer, Adjuvant Therapy | Status: COMPLETED | Results posted: 2025-10-06